ESC Premium Access

Are we being able to meet current guidelines LDL-cholesterol goals in very high risk patients? How many of them could benefit of PSCK9 inhibition by the FOURIER/ODYSSEY and NICE criteria?

Congress Presentation

About the speaker

Doctor Tamer El Andere

Institute Dante Pazzanese of Cardiology, Sao Paulo (Brazil)
0 follower

13 more presentations in this session

Reduction in high-sensitivity C-reactive protein by pitavastatin was associated with improved outcomes in Japanese patients with stable coronary artery disease: results from REAL-CAD study

Speaker: Doctor H. Iwata (Tokyo, JP)

Thumbnail

The association of Lp(a) levels and cardiovascular disease in adult patients with familial hypercholesterolemia: analysis from the HELLAS-FH registry

Speaker: Professor E. Liberopoulos (Athens, GR)

Thumbnail

Oxidized phospholipids on apolipoprotein B-100 among black US adults with and without PCSK9 loss-of-function variants

Speaker: Doctor M. Mefford (Birmingham, US)

Thumbnail

HDL-C and all-cause mortality in a high-risk population: impact of LDL-C

Speaker: Doctor D. Dhindsa (Atlanta, US)

Thumbnail

Children with familial hypercholesterolemia: lipid profile, treatment and evaluation of different formulas for calculating low-density lipoprotein cholesterol: an analysis from the HELLAS-FH registry

Speaker: Professor E. Liberopoulos (Athens, GR)

Thumbnail

Access the full session

Poster Session 6 - Lipids

Speakers: Doctor T. El Andere, Doctor H. Iwata, Professor E. Liberopoulos, Doctor M. Mefford, Doctor D. Dhindsa...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk